What Is CollPlant Biotechnologies Ltd. (CLGN) Worth in 2026?
According to the CirclFi Deep Alpha Valuation Engine, CollPlant Biotechnologies Ltd.'s intrinsic value is estimated at $0.39, presenting a divided outlook at the current price of $0.35. With an average implied return of +12.6% across a split 6–4 (bull–bear) consensus, the model spread of +185.0% underscores analytical uncertainty. Notably, FTNN sees the most upside at +105.1% (fair value: $0.72), while Bayesian DCF is the most conservative at -79.8% ($0.07). The spread between these extremes — +185.0% — reveals how different analytical frameworks can reach starkly different conclusions.
What Do the Models Say About CLGN?
11 of 13 models are currently active for CLGN. Of these, 7 models suggest upside while 4 models suggest overvaluation. The Bayesian DCF estimates CLGN's intrinsic value at $0.07, implying -79.8% downside from the current price. See which stocks rank higher →
How Does CLGN Rank in Orthopedic, Prosthetic & Surgical Appliances & Supplies?
Among 25 Orthopedic, Prosthetic & Surgical Appliances & Supplies stocks, CLGN ranks #24 by Quality of Company score. CirclFi's QOC score of 2.9/10 evaluates 32 fundamental signals. A score of 2.9 signals below-average fundamentals.
CollPlant Biotechnologies Ltd. operates in a competitive landscape where fundamental quality metrics are key differentiators for long-term value creation.
Is CLGN a Value Trap?
The Value Trap algorithm is not active for CLGN. The score cross-references apparent undervaluation against fundamental deterioration signals. Browse lowest value-trap stocks →
Multi-Model Methodology
11 of 13 models are active for CollPlant Biotechnologies Ltd.. Broad coverage provides high confidence. Each model applies a fundamentally different valuation philosophy. See the complete methodology →
According to the CirclFi Quality of Company (QOC) framework, CollPlant Biotechnologies Ltd. earns a quality score of 2.9/10. This concerning rating reflects the company's standing across 32 fundamental signals spanning profitability, growth consistency, balance sheet strength, and capital allocation efficiency.
The gap between the most bullish and bearish model spans +185.0% — demonstrating why single-model analysis is dangerous. Browse all stocks with 13-model coverage →
Data Sources & Confidence
Every CLGN valuation is built from SEC EDGAR XBRL filings — 700+ standardized financial tags. Macroeconomic context from FRED calibrates discount rates, while GDELT news sentiment feeds into our Sentiment SOTP model. All pipelines run daily. Read the complete data methodology →
Across CLGN's 11 active models, average confidence is 12%. Lower confidence may reflect limited history or high volatility.
CirclFi's output is a research starting point, not a buy/sell signal. All data updates daily. Read the full methodology →
Buy with Gumroad